Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Wild-Type vs BTP2 Treated Th1 and Pathogenic Th17 cells_ 96h

ABSTRACT: Transicriptome comparison between murine WT and BTP2 Treated Th1 and pTH17cells at 96 hours following differentiation

ORGANISM(S): Mus musculus

PROVIDER: GSE287007 | GEO | 2026/01/24

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Wild-Type vs BTP2 Treated Th1 and Pathogenic Th17 cells_ 96h

Project description:Wild-Type vs BTP2 Treated Th1 and Pathogenic Th17 cells_ 96h

| PRJNA1210684 | ENA

TCR sequencing of pathogenic and non pathogenic Th1 and Th17 cells subsets

Project description:Th1 and Th17 cell subsets were sort-purified (FACSAria III, BD Biosciences, or Aurora CS, Cytek) from peripheral blood of HD and CF patients, or from lung-tissues of CF and non-CF patients, according to the expression of specific surface markers combination among CD4+IL-7R+CD25low cells: CCR6-CXCR3+ (Th1 cells), CCR6+CXCR3-CCR5- (cTh17 cells), CCR6+CXCR3-CCR5+ (pTh17 cells), CCR6+CXCR3+CCR5- (Th1/17- cells), CCR6+CXCR3+CCR5+ (Th1/17+ cells).

2026-07-14 | E-MTAB-15769 | biostudies-arrayexpress

RNA-sequencing of pathogenic and non pathogenic Th1 and Th17 cell subsets

2026-07-14 | E-MTAB-15774 | biostudies-arrayexpress

Foxo3 drives pathogenic Th1 differentiation

Project description:We showed that the transcription factor Foxo3 played a specific role in the polarization of CD4+ T cells towards pathogenic Th1 cells producing both interferon-γ (IFN-γ) and granulocyte monocyte colony stimulating factor (GM-CSF). To understand the molecular mechanisms whereby Foxo3 controls CD4+ T cell differentiation, unbiased analysis of genes differentially expressed in Foxo3-deficient vs. Foxo3-sufficient CD4+ T cells was achieved using both resting and activated CD4+ T cells obtained following 12 or 24 hours of stimulation with anti-CD3 mAbs.

2016-09-01 | GSE86287 | GEO

Retinoic acid signaling constrains the plasticity of Th1 cells and prevents development of pathogenic Th17 cells [Affymetrix experiments]

Project description:CD4+ T cells differentiate into phenotypically distinct T-helper cells upon antigenic stimulation. Regulation of plasticity between these CD4+ T-cell lineages is critical for immune homeostasis and prevention of autoimmune diseases. However, the factors that regulate lineage stability are largely unknown. Here we investigate a role for retinoic acid (RA) in the regulation of lineage stability using T helper 1 (Th1) cells, traditionally considered the most phenotypically stable Th subset. We found that RA, through its receptor RARa, sustains stable expression of Th1 lineage specifying genes as well as repressing genes that instruct Th17 cell fate. RA signaling is essential for limiting Th1 cell conversion into Th17 effectors and for preventing pathogenic Th17 responses in vivo. Our studies identify RA-RARa as a key component of the regulatory network governing Th1 cell fate and define a new paradigm for the development of pathogenic Th17 cells. These findings have important implications for autoimmune diseases in which dysregulated Th1-Th17 responses are observed. IFN-gamma+ Th1 cells from IFNgeYFP reporter mouse; comparing dnRARa to WT

2015-03-10 | E-GEOD-60354 | biostudies-arrayexpress

The antitumor function of Th17-derived Th1 cell is better than traditional Th1 and Th17 cells

Project description:Th17 cells have better stemness and differentiation potential, and under certain circumstances, they can be stimulated to differentiate into other subcelltypes including Th1 and Treg. Here, we report that compared to traditional Th1 and Th17 cells, Th17-derived Th1 cells had greater anti-tumor activity. Both C57 mice ACT therapy and CAR-T therapy models were used to validate it. Mechanism: Th17-derived Th1 cells are able to express Th1 effector molecules as well as retain a lower level of exhaustion than Th1 cells. Additionally, it has a higher amount of type 1 interferon response and a stronger capacity for migration. Our research offers a fresh perspective on how ACT therapy and CAR-T therapy might develop in the future.

2024-10-31 | GSE276409 | GEO

Retinoic acid signaling constrains the plasticity of Th1 cells and prevents development of pathogenic Th17 cells [ChIP-Seq experiments]

Project description:CD4+ T cells differentiate into phenotypically distinct T-helper cells upon antigenic stimulation. Regulation of plasticity between these CD4+ T-cell lineages is critical for immune homeostasis and prevention of autoimmune diseases. However, the factors that regulate lineage stability are largely unknown. Here we investigate a role for retinoic acid (RA) in the regulation of lineage stability using T helper 1 (Th1) cells, traditionally considered the most phenotypically stable Th subset. We found that RA, through its receptor RARa, sustains stable expression of Th1 lineage specifying genes as well as repressing genes that instruct Th17 cell fate. RA signaling is essential for limiting Th1 cell conversion into Th17 effectors and for preventing pathogenic Th17 responses in vivo. Our studies identify RA-RARa as a key component of the regulatory network governing Th1 cell fate and define a new paradigm for the development of pathogenic Th17 cells. These findings have important implications for autoimmune diseases in which dysregulated Th1-Th17 responses are observed. Identification of RARa binding in wild-type Th1 cells and mapping of enhancers using chromatin IP against p300, H3k4me1, H3k4me3, and H3k27ac in wild-type and dnRara Th1 cells.

2015-03-10 | E-GEOD-60353 | biostudies-arrayexpress

TCR sequencing of pathogenic and non pathogenic Th1 and Th17 cells subsets

Project description:TCR sequencing of pathogenic and non pathogenic Th1 and Th17 cells subsets

| PRJEB101003 | ENA

RNA-sequencing of pathogenic and non pathogenic Th1 and Th17 cell subsets

Project description:RNA-sequencing of pathogenic and non pathogenic Th1 and Th17 cell subsets

| PRJEB101056 | ENA

Retinoic acid signaling constrains the plasticity of Th1 cells and prevents development of pathogenic Th17 cells [Agilent experiments]

2015-03-10 | GSE60355 | GEO